Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging
- PMID: 35237597
- PMCID: PMC8883344
- DOI: 10.3389/fcell.2022.793328
Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging
Abstract
Efficient proteostasis is crucial for somatic maintenance, and its decline during aging leads to cellular dysfunction and disease. Selective autophagy is a form of autophagy mediated by receptors that target specific cargoes for degradation and is an essential process to maintain proteostasis. The protein Sequestosome 1 (p62/SQSTM1) is a classical selective autophagy receptor, but it also has roles in the ubiquitin-proteasome system, cellular metabolism, signaling, and apoptosis. p62 is best known for its role in clearing protein aggregates via aggrephagy, but it has recently emerged as a receptor for other forms of selective autophagy such as mitophagy and lipophagy. Notably, p62 has context-dependent impacts on organismal aging and turnover of p62 usually reflects active proteostasis. In this review, we highlight recent advances in understanding the role of p62 in coordinating the ubiquitin-proteasome system and autophagy. We also discuss positive and negative effects of p62 on proteostatic status and their implications on aging and neurodegeneration. Finally, we relate the link between defective p62 and diseases of aging and examine the utility of targeting this multifaceted protein to achieve proteostatic benefits.
Keywords: aging; autophagy; neurodegenerative diseases; p62 (sequestosome 1(SQSTM1)); proteasome.
Copyright © 2022 Kumar, Mills and Lapierre.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

References
-
- Al-Sarraj S., King A., Troakes C., Smith B., Maekawa S., Bodi I., et al. (2011). p62 Positive, TDP-43 Negative, Neuronal Cytoplasmic and Intranuclear Inclusions in the Cerebellum and hippocampus Define the Pathology of C9orf72-Linked FTLD and MND/ALS. Acta Neuropathol. 122, 691–702. 10.1007/s00401-011-0911-2 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources